Company intelligence / Profile preview

Squizzical

Ownership: Private
Development stage: Other

Overview

Squizzical is an Australian consulting firm specializing in business development and research commercialization for organizations in life sciences and related fields. The company has supported over 100 clients with projects ranging from technology transfer reviews to IP valuation for cancer drug candidates and strategic planning for mental health research commercialization. It does not itself develop drugs or maintain a therapeutic pipeline but provides expertise to organizations that do.

Industry: Consulting

Partnerships

Confidential; works with >100 organizations across academia and industry

Beyond the preview

Go deeper on Squizzical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Squizzical.

Explore the full profile